Xarelto MDL Sent to Eastern District of Louisiana; City of St. Louis Xarelto Litigation Expected to Begin Soon

Share Article

NGK Law has filed a Xarelto lawsuit in the U.S. District Court for the Southern District of Illinois, Williams v. Janssen Research & Development, LLC et. al, Cause no. 3:14 cv-01278, which will be transferred into the MDL

NGK Law’s goal is to provide the best and most efficient forum for its clients’ Xarelto lawsuits, and believes that by expanding into St. Louis state court litigation, this can be obtained for Xarelto lawsuit clients.

According to court documents, on December 12, 2014 the United States Judicial Panel on Multi-District Litigation (JPML) entered an Order transferring all of the federal court Xarelto lawsuits to the Eastern District of Louisiana.    The Xarelto MDL has been given MDL number 2592. The JPML decided on the Eastern District of Louisiana because it found it to be a geographically central forum for nationwide Xarelto lawsuits. Additionally, it determined that Judge Eldon Fallon, who presides over the Xarelto lawsuit MDL, is an experienced transferee judge with the willingness and ability to manage the Xarelto lawsuit litigation efficiently. The JPML also cited that Judge Fallon is “well versed in multi-district litigation,” and the JPML was “confident he will steer this matter on a prudent course.” A complete copy of the JPML court’s Xarelto MDL order can be found at http://www.jpml.uscourts.gov/sites/jpml/files/MDL-2592-Initial_Transfer-12-14.pdf

According to the court’s order, the Xarelto lawsuit Plaintiffs had proposed several locations for the consolidation of the nationwide Xarelto lawsuits, including the Southern District of Illinois, the Northern District of Georgia, the Northern District of Illinois, and the Eastern District of Louisiana, among other locations. The Xarelto lawsuit Defendants had opposed the creation of an MDL, and had alternatively suggested the District of New Jersey would be an appropriate transferee district. The Xarelto lawsuit Defendants include various Bayer Corporation entities, as well as Janssen Pharmaceutical affiliates, with the addition of Johnson & Johnson affiliates as well. Despite the Xarelto lawsuit Defendants’ argument that the litigation lacks merit, the JPML determined that the creation of MDL in the Eastern District of Louisiana is in the best interest of all concerned. http://www.jpml.uscourts.gov/sites/jpml/files/MDL-2592-Initial_Transfer-12-14.pdf

To date, NGK Law has filed a Xarelto lawsuit in the U.S. District Court for the Southern District of Illinois, Williams v. Janssen Research & Development, LLC et. al, Cause no. 3:14 cv-01278, which will be transferred into the MDL. A St. Louis litigation also benefits its clients, as it gives clients a state court litigation separate from the federal MDL litigation. NGK Law’s goal is to provide the best and most efficient forum for its clients’ Xarelto lawsuits, and believes that by expanding into St. Louis state court litigation, this can be obtained for Xarelto lawsuit clients. NGK Law is actively litigating other pharmaceutical cases in St. Louis, including cases involving Androgel prescription testosterone gel, Hebron v. Abbvie, et. al, Cause no. 1422-CC09740-01.

The law firm of Niemeyer, Grebel & Kruse, LLC, has created a website called http://www.xareltorivaroxabanlawcenter.com, which is devoted to helping those allegedly injured by the blood thinning medication Xarelto to understand their avenues for pursuing a Xarelto lawsuit.

NGK Law is evaluating cases for individuals, or family members of individuals, that have suffered from serious bleeding events, including hemorrhagic strokes and gastrointestinal bleeds, allegedly while taking Xarelto.

About Niemeyer, Grebel & Kruse, LLC

Niemeyer, Grebel & Kruse, LLC is a St. Louis based mass tort and personal injury law firm handling pharmaceutical and medical device injury and death cases around the United States. Its track record of assisting those injured by dangerous drugs and medical devices shows its unending commitment to its clients and to holding pharmaceutical drug manufacturers and medical device manufacturers accountable for their dangerous products. Given its experience and accomplishment in being recognized by federal courts to lead litigation on behalf of thousands of individuals, NGK Law is considered a nationwide leader in pharmaceutical and drug litigation. The NGK Law Firm Xarelto lawyers provide information to the public at http://www.xareltorivaroxabanlawcenter.com.

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

David Grebel
NGK Law Firm
+1 314-241-1919
Email >
Visit website